To further illustrate the potential role of ZBTB42 in glioma, we applied Lasso regression on the DEGs between the high ZBTB42 expression group and low expression group in LGG patients (Figures 7A, B). This evidence concerns the gene ZBTB42 and central nervous system cancer.